KRRO
Frequency Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$200.62M
P/E Ratio
—
EPS
$-12.48
Beta
2.43
52W High
$55.89
52W Low
$5.20
50-Day MA
$11.75
200-Day MA
$18.63
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Frequency Therapeutics Inc
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | $6.39M |
| Gross Profit (TTM) | $-48.74M |
| EBITDA | $-83.06M |
| Operating Margin | -1229.00% |
| Return on Equity | -110.70% |
| Return on Assets | -32.10% |
| Revenue/Share (TTM) | $0.68 |
| Book Value | $5.46 |
| Price-to-Book | 3.92 |
| Price-to-Sales (TTM) | 31.39 |
| EV/Revenue | 26.63 |
| EV/EBITDA | -5.60 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -43.10% |
| Shares Outstanding | $14.42M |
| Float | $9.58M |
| % Insiders | 4.30% |
| % Institutions | 78.73% |
Analyst Ratings
Consensus ($20.00 target)
1
Strong Buy5
Buy3
HoldData last updated: 4/8/2026